Updates Amyloidosis Conference

Join us for upcoming Amyloidosis events:

Updates in Amyloidosis

The Institute for Future Health (IFH), Updates in Amyloidosis steering committee is led by Sandesh Dev, MD, Arizona State University, strive to advance the understanding and management of amyloidosis. The committee brings together leading Valley experts in cardiology and amyloidosis, a primary rapidly emerging topic that interconnects several medical specialists from cardiovascular and neurologic conditions, to renal and pulmonary complications, creating a multi-organ involvement if left undiagnosed/or not properly treated. There is a huge gap of unmet needs for patients with this condition, and all health professionals, especially those in cardiology, neurology, hematology, imaging, and primary care are all areas of current focal points of our discussions.

UPCOMING EVENTS:

We are pleased to announce the Save-the-Date for The Updates in Amyloidosis CME Conference 2025 organized by the Amyloidosis Steering Committee led by Sandesh Dev, MD, Arizona State University, which is under the CASI organization. Save-the-Date: Saturday, February 1, 2025 Where: ASU Health Futures, 6161 E. Mayo Blvd, Phoenix, AZ 85054 In-Person and Virtual (onsite hotel and free parking) Questions: Email [email protected] or call 480-727-8661 More details forthcoming in September 2024 Embedded Image Amyloidosis 2025

FEATURED PAST EVENTS

PAST PRESENTATIONS:

  • PAST PRESENTATIONS: ASU-VA Data Agenda 2.2.2024
    Presentations:
    8:30-8:40 AM- Introduction, Sandesh Dev, MD- Director, Cardiovascular Disease Projects; Institute For Future Health, ASU/UA
    8:40 – 9:00 am Collaboration Pathways with VA, Amanda Lienau, PhD- Director of Data and Analytics Innovation; VA Office Of Healthcare Innovation and Learning, Washington, DC
    Voices of the Investigators
    10:15 – 10:30 am Use of EHR to Predict Dementia Conversion in Veterans with MCI, Raymond Migrino, MD- Clinical Professor; Phoenix VA Healthcare System
    10:30 – 10:45 am Epidemiology of Cardiac Amyloidosis in Veterans, Simar Singh, MD, PhD- Internal Medicine Resident; Tucson VA & University of Arizona College of Medicine
    Partnering with Arizona VA Medical Centers for Research
    11:20 – 11:40 am Phoenix VA Research Opportunities Overview & VIREC, Paska Permana, PhD- Deputy Associate Chief of Staff for Research, Phoenix VA Healthcare System; Janet Fawcett, PhD- Health Scientist and Methodologist, Phoenix VA Healthcare System
    Planning for the Future of Arizona Clinical and Health Informatics Research and Training
    11:40 – 12:00 pm R. Ken Coit College of Pharmacy Collaborations and Opportunities
    Bonnie LaFleur, PhD- Research Professor & Director of Health Outcomes & PharmacoEconomic Research (HOPE) Center; University of Arizona; Travis Wheeler, PhD- Associate Professor; University of Arizona
    12:00 – 12:20 pm Partnering with Data and Health Hubs at ASU
    Michael Simeone, PhD- Associate Research Professor; School of Complex Adaptive Systems, ASU
  • Cardiac Amyloidosis Research Seminar 8.17.23 @ 5:30PM Dinner; 6:30PM Debate
    ASU-Mayo Health Futures Center, Phoenix 
    https://theifh.org/news/story/cardiac-amyloidosis-research-seminar-series-cars-thursday-august-17-2023-630-pm/
    The virtual and in-person meeting brought together leading Valley experts in cardiology and primary care for an in-depth discussion on the challenge of proactive screening and detection of cardiac amyloidosis. The debate centered around the question: 
    All Elderly (65+) Heart Failure Patients SHOULD/SHOULD NOT be Screened for Cardiac Amyloidosis
    This event was sponsored by a grant from Arizona Biomedical Research Consortium.
  • Updates in Cardiac Amyloidosis 2023 – Health Futures Center – Saturday, 14 January 2023
    Health Futures Center 
    The Institute for Future Health hosted a hybrid (in-person and Livestream) conference focused on building the
    knowledge of cardiac amyloidosis amongst Arizona clinicians. This event was exclusively dedicated to cardiac amyloidosis a disease of protein misfolding that leads to congestive heart disease, disabling neuropathy, and other systemic conditions. Cardiac Amyoidosis can be caused by transthyretin or light-chain amyloidosis. the pace of knowledge in this field is greatly accelerating, and it is important for clinicians and scientists

    • FEATURED VIDEOS: